Rolf-Peter Ryseck
Impact in
- Cancer Research top 0.5%
- NF-κB Signaling Pathways
- Immunology top 1%
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- interferon and immune responses
- T-cell and B-cell Immunology
Papers in
-
- NF-κB Signaling Pathways 15
- Cancer, Hypoxia, and Metabolism 4
-
- Genomics, phytochemicals, and oxidative stress 4
- Co-authors
- R Bravo (13 shared papers)Moshé Yaniv (4 shared papers)Syu-ichi Hirai (3 shared papers)Rodrigo Bravo (11 shared papers)Daniel R. Carrasco (6 shared papers)Rodrigo Bravo (5 shared papers)Paweł Dobrzański (5 shared papers)Falk Weih (5 shared papers)
- Journals
- Molecular and Cellular Biology (8 papers)The EMBO Journal (6 papers)Blood (2 papers)Development (2 papers)Cancer Research (2 papers)
- Partner nations
- United StatesGermanyFrance
In The Last Decade
Rolf-Peter Ryseck
46 papers receiving 5.2k citations
Rolf-Peter Ryseck's Hit Papers
Peers
Comparison fields: 5 of 112
- Cancer Research 2.0k
- Immunology 2.2k
- Cellular and Molecular Neuroscience 795
- Oncology 977
- Molecular Biology 2.6k
Countries citing papers authored by Rolf-Peter Ryseck
This map shows the geographic impact of Rolf-Peter Ryseck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf-Peter Ryseck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf-Peter Ryseck more than expected).
Fields of papers citing papers by Rolf-Peter Ryseck
This network shows the impact of papers produced by Rolf-Peter Ryseck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf-Peter Ryseck. The network helps show where Rolf-Peter Ryseck may publish in the future.
Co-authors
The 25 scholars most cited alongside Rolf-Peter Ryseck, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family Hit paper breakdown → | 1995 | 689 |
| 2 | Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts Hit paper breakdown → | 1988 | 526 |
| 3 | The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. Hit paper breakdown → | 1989 | 503 |
| 4 | 1989 | 439 | |
| 5 | 1992 | 319 | |
| 6 | 1992 | 254 | |
| 7 | 2011 | 214 | |
| 8 | 1998 | 200 | |
| 9 | 1989 | 166 | |
| 10 | 1997 | 155 | |
| 11 | 1989 | 154 | |
| 12 | 1993 | 131 | |
| 13 | 1986 | 116 | |
| 14 | 1996 | 112 | |
| 15 | 1992 | 111 | |
| 16 | 1994 | 105 | |
| 17 | 1998 | 92 | |
| 18 | 1997 | 78 | |
| 19 | Identification of an immediate early gene, pghs-B, whose protein product has prostaglandin synthase/cyclooxygenase activity. | 1992 | 78 |
| 20 | 1992 | 76 |
About Rolf-Peter Ryseck
Rolf-Peter Ryseck is a scholar working on Cancer Research, Molecular Biology, Immunology, Oncology and Cell Biology, having authored 46 papers that have together received 5.4k indexed citations. Recurring topics across this work include NF-κB Signaling Pathways (15 papers), Immune Response and Inflammation (8 papers), interferon and immune responses (6 papers), Cytokine Signaling Pathways and Interactions (6 papers), Immune Cell Function and Interaction (5 papers), Genomics, phytochemicals, and oxidative stress (4 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Physiological and biochemical adaptations (3 papers). The work is most often cited by research in Cancer Research (2.0k citations), Immunology (2.2k citations), Cellular and Molecular Neuroscience (795 citations), Oncology (977 citations) and Molecular Biology (2.6k citations). Rolf-Peter Ryseck has collaborated with scholars based in United States, Germany and France. Frequent co-authors include R Bravo, Moshé Yaniv, Syu-ichi Hirai, Rodrigo Bravo, Daniel R. Carrasco, Rodrigo Bravo, Paweł Dobrzański, Falk Weih, Marino Zerial and Ulrich Siebenlist. Their work appears in journals such as Molecular and Cellular Biology, The EMBO Journal, Blood, Development and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.